Argyrios G. Arvanitis,James D. Rodgers,Louis Storace,Beverly Folmer
申请号：
US13834040
公开号：
US08841318B2
申请日:
2013.03.15
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The present invention provides substituted tricyclic heteroaryl compounds, including, for example, pyridoindoles, pyrimidinoindoles and triazinoindoles that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases such as immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases.
